Posaconazole and Rifabutin interaction

Posaconazole and Rifabutin: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Posaconazole (NOXAFIL) label · effective 2026-02-13

Major

Rifabutin Avoid concomitant use of posaconazole with rifabutin unless the benefit to the patient outweighs the risk.

Drug interactionsnames RifabutinView label on DailyMed
Major

Prevention or Management Avoid concomitant use of posaconazole with rifabutin unless the benefit outweighs the risk.

Drug interactionsnames RifabutinView label on DailyMed
Moderate

See Table 17 for rifabutin monitoring considerations when posaconazole affects rifabutin via CYP3A4 inhibition.

Drug interactionsnames RifabutinView label on DailyMed
Moderate

Concomitant use of posaconazole with rifabutin increased rifabutin plasma concentrations [see Clinical Pharmacology (12.3) ].

Drug interactionsnames RifabutinView label on DailyMed
Moderate

Frequent monitoring of full blood counts and adverse reactions due to increased rifabutin plasma concentrations (e.g., uveitis, leukopenia) during concomitant use are recommended.

Drug interactionsnames RifabutinView label on DailyMed

From the Rifabutin label · effective 2026-09-01

Major

Posaconazole 200 mg once a day for 10 days 300 mg once a day for 17 days Healthy subjects (8) ↑ AUC by 72%, ↑ C max by 31% ↓ AUC by 49%, ↓ C max by 43% If co-administration of these two drugs cannot be avoided, patients should be monitored for adverse events associated with rifabutin administration, and lack of posaconazole efficacy.

Drug interactionsnames PosaconazoleView label on DailyMed
Moderate

Effect of Other Drugs on Rifabutin Pharmacokinetics Some drugs that inhibit CYP3A may significantly increase the plasma concentration of rifabutin.

Drug interactionsby drug classView label on DailyMed
Moderate

Therefore, carefully monitor for rifabutin associated adverse events in those patients also receiving CYP3A inhibitors, which include fluconazole and clarithromycin.

Drug interactionsby drug classView label on DailyMed
Moderate

In some cases, the dosage of rifabutin may need to be reduced when it is co-administered with CYP3A inhibitors.

Drug interactionsby drug classView label on DailyMed
Moderate

ANTIFUNGALS Fluconazole 200 mg once a day for 2 weeks 300 mg once a day for 2 weeks HIV-infected patients (12) ↑ AUC by 82%, ↑ C max by 88% ↔ Monitor for rifabutin associated adverse events.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.